BlueBird Bio’s two drugs for rare diseases that each cost about $3 million — the most expensive drugs on the market — are fairly priced, the chief operating officer at a rival drugmaker told Bloomberg in an Oct. 5 report.
Read the full post on Becker's Hospital Review - Healthcare News
